Literature DB >> 32695637

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy.

Jennifer J Rayner1, Ines Abdesselam1, Joanna d'Arcy1, Saul G Myerson1, Stefan Neubauer1, Hugh Watkins2, Vanessa M Ferreira1, Oliver J Rider1.   

Abstract

BACKGROUND: Obesity causes significant cardiac remodelling even in health, and yet the contribution of this maladaptation in the setting of an additional cardiomyopathic process is poorly understood. Cardiovascular magnetic resonance is the gold-standard tool for assessing cardiac geometry, especially in an obese population, and hence perfectly suited to investigate this important question.
METHODS: Using data from our extensive imaging registry (n=1,554), we documented the relationship between increasing BMI and left ventricular (LV) remodelling in patients with dilated (DCM; n=529) and hypertrophic cardiomyopathy (HCM; n=297), compared to the normal heart (n=728).
RESULTS: Regardless of cardiac status, increasing BMI resulted in similar increases in LV stroke volume (P>0.18). However, there was a difference in the degree of LV cavity dilatation associated with this change in stroke volume; when compared to normal hearts [increase in end-diastolic volume of 0.7 mL per unit of rising BMI (mL/kg/m2)], there was a threefold greater LV cavity dilatation in DCM (+2.2 mL/kg/m2) and twofold greater in HCM (+1.9 mL/kg/m2, all P<0.04). Whilst obesity was related to LV hypertrophy in all groups (normal +1.3 g, DCM +2.2g, HCM +2.3 g/kg/m2, all P<0.001), additional obesity-related concentric LV remodelling only occurred in normal hearts and DCM (normal +0.006 vs. +0.003 mass:volume ratio, both P<0.001).
CONCLUSIONS: In both DCM and HCM, the increase in stroke volume required by obesity appears to be achieved by excessive LV cavity dilatation. The impact of obesity on LV geometry was more pronounced in concomitant cardiovascular disease, and therefore carries potential to become an important therapeutic target in cardiomyopathy. 2020 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Obesity; cardiac MR; cardiomyopathy; hypertrophy; remodelling

Year:  2020        PMID: 32695637      PMCID: PMC7369279          DOI: 10.21037/cdt-19-587

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  24 in total

1.  Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.

Authors:  Jose Angel Urbano-Moral; Ethan J Rowin; Martin S Maron; Andrew Crean; Natesa G Pandian
Journal:  Circ Cardiovasc Imaging       Date:  2013-11-25       Impact factor: 7.792

2.  Risk of Heart Failure in Obese Patients With and Without Bariatric Surgery in Sweden-A Registry-Based Study.

Authors:  Christina E Persson; Lena Björck; Jesper Lagergren; Georgios Lappas; Kok Wai Giang; Annika Rosengren
Journal:  J Card Fail       Date:  2017-05-12       Impact factor: 5.712

3.  Ventricular hypertrophy and cavity dilatation in relation to body mass index in women with uncomplicated obesity.

Authors:  Oliver J Rider; Steffen E Petersen; Jane M Francis; Mohammed K Ali; Lucy E Hudsmith; Monique R Robinson; Kieran Clarke; Stefan Neubauer
Journal:  Heart       Date:  2010-05-18       Impact factor: 5.994

4.  Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular hypertrophy after long-term follow-up.

Authors:  Arun Krishnamoorthy; Timothy Brown; Colby R Ayers; Sachin Gupta; J Eduardo Rame; Parag C Patel; David W Markham; Mark H Drazner
Journal:  Am J Cardiol       Date:  2011-07-27       Impact factor: 2.778

5.  Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction.

Authors:  Richard V Milani; Mark H Drazner; Carl J Lavie; Daniel P Morin; Hector O Ventura
Journal:  Am J Cardiol       Date:  2011-07-23       Impact factor: 2.778

6.  Compensatory and noncompensatory left ventricular dilatation after myocardial infarction: time course and hemodynamic consequences at rest and during exercise.

Authors:  P Gaudron; C Eilles; G Ertl; K Kochsiek
Journal:  Am Heart J       Date:  1992-02       Impact factor: 4.749

7.  Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity.

Authors:  Oliver J Rider; Jane M Francis; Mohammed K Ali; Steffen E Petersen; Monique Robinson; Matthew D Robson; James P Byrne; Kieran Clarke; Stefan Neubauer
Journal:  J Am Coll Cardiol       Date:  2009-08-18       Impact factor: 24.094

8.  Obesity and the risk of heart failure.

Authors:  Satish Kenchaiah; Jane C Evans; Daniel Levy; Peter W F Wilson; Emelia J Benjamin; Martin G Larson; William B Kannel; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

9.  Gender-specific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging.

Authors:  Oliver J Rider; Adam Lewandowski; Richard Nethononda; Steffen E Petersen; Jane M Francis; Alex Pitcher; Cameron J Holloway; Sairia Dass; Rajarshi Banerjee; James P Byrne; Paul Leeson; Stefan Neubauer
Journal:  Eur Heart J       Date:  2012-10-10       Impact factor: 29.983

10.  Concentric left ventricular remodeling and aortic stiffness: a comparison of obesity and hypertension.

Authors:  Oliver J Rider; Richard Nethononda; Steffen E Petersen; Jane M Francis; James P Byrne; Paul Leeson; Kieran Clarke; Stefan Neubauer
Journal:  Int J Cardiol       Date:  2012-10-02       Impact factor: 4.164

View more
  1 in total

Review 1.  Unraveling the Genotype-Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity-Related Cardiac Defects as a Major Disease Modifier.

Authors:  Edgar E Nollet; B Daan Westenbrink; Rudolf A de Boer; Diederik W D Kuster; Jolanda van der Velden
Journal:  J Am Heart Assoc       Date:  2020-11-11       Impact factor: 6.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.